MESOTHELIOMA CHEMOTHERAPY DRUG TRIALS

Malignant mesothelioma drug trials revolve around the testing of newly developed mesothelioma treatment modalities designed to combat the fatal cancer. Traditional mesothelioma cancer treatments have been unable to provide containment of the disease, forcing researchers to develop and implement new malignant mesothelioma cancer treatment options. Malignant mesothelioma drug trials testing new chemotherapy drugs are ongoing and believed to be capable of producing significant advancements in the treatment of malignant mesothelioma.

One of the newer chemotherapy drugs being researched and developed for the treatment of malignant mesothelioma that is currently receiving a great deal of attention is Alimta (pemetrexed) with Cisplatin. A non-chemotherapy drug currently being researched is Veglin (anti-angiogenesis drug).

Learn more about Alimta trials.

Learn more about Veglin trials.